The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; 22 of the 28 sources its claims cite were checked for support.
Characterizing the molecular regulation of inhibitory immune checkpoints with multimodal single-cell screens
Open accessPublished version of a preprint
Abstract
The expression of inhibitory immune checkpoint molecules, such as programmed death-ligand (PD-L)1, is frequently observed in human cancers and can lead to the suppression of T cell-mediated immune responses. Here, we apply expanded CRISPR-compatible (EC)CITE-seq, a technology that combines pooled CRISPR screens with single-cell mRNA and surface protein measurements, to explore the molecular networks that regulate PD-L1 expression. We also develop a computational framework, mixscape, that substantially improves the signal-to-noise ratio in single-cell perturbation screens by identifying and removing confounding sources of variation. Applying these tools, we identify and validate regulators of PD-L1 and leverage our multimodal data to identify both transcriptional and post-transcriptional modes of regulation. Specifically, we discover that the Kelch-like protein KEAP1 and the transcriptional activator NRF2 mediate the upregulation of PD-L1 after interferon (IFN)-γ stimulation. Our results identify a new mechanism for the regulation of immune checkpoints and present a powerful analytical framework for the analysis of multimodal single-cell perturbation screens.
Overview
CoChat Summary
TL;DR
The paper applies ECCITE-seq, combining pooled CRISPR screens with single-cell mRNA and surface protein measurements, to map regulators of PD-L1 in THP-1 cells after IFNγ stimulation. It introduces mixscape to remove non-perturbed “escaping” cells and identifies KEAP1/NRF2 and CUL3 as regulators of PD-L1, including an indirect transcriptional mechanism through NRF2.
Key findings
- ECCITE-seq profiled 111 gRNAs across three independent transductions; from 30,328 cells, 22,606 had detectable gRNA expression and 22,573 could be assigned to an individual perturbation.
- A subset of cells expressing the same gRNA escaped perturbation: for IFNGR2g2, 74% of 1,193 gRNA-expressing cells were in the perturbed cluster, while 26% were indistinguishable from non-targeting controls; escaping cells often carried in-frame INDELs.
- Mixscape classified perturbation rates across gRNAs, including IRF1 gRNAs ranging from 39% to 92%, and identified eight genes whose perturbation shifted PD-L1 protein levels: five positive regulators and three negative regulators, including BRD4 and CUL3.
- CUL3 perturbation increased PD-L1 mRNA 1.6-fold (p < 10^-11) and showed strong enrichment for NRF2 pathway target genes (p < 10^-14); NRF2 overexpression and KEAP1 perturbation upregulated PD-L1 mRNA and protein, supporting CUL3-KEAP1 as an indirect regulator of PD-L1 transcription via NRF2.
Methods
- CITE-seq was performed on stimulated and unstimulated THP-1 cells, yielding 7,566 single-cell profiles with transcriptomes and surface protein levels for PD-L1, PD-L2, and CD86; 26 genes were selected from the top 200 genes correlated with PD-L1 expression for functional screening.
- ECCITE-seq used a pooled sgRNA library of 111 guides, three independent transductions at low MOI, doxycycline-inducible Cas9, and 90% stimulated cells; libraries were sequenced on Illumina NovaSeq with 55,300 average mRNA reads/cell.
- Analyses included PCA/UMAP, local perturbation signatures using k=20 nearest non-targeting neighbors, mixscape Gaussian mixture modeling, LDA, differential expression, gene set enrichment, flow cytometry validation, a focused CRISPR validation screen, and bulk RNA-seq after NRF2 overexpression or KEAP1/BRD4 perturbation.
Limitations
- Stated: mixscape relies on detecting transcriptomic shifts, so perturbations that alter epigenetic state, protein levels, or functional responses without transcriptomic change will be classified as non-perturbed; its binary classification is likely an oversimplification.
- Stated: future work could use integrative multi-modal approaches to jointly analyze transcriptome and protein levels when filtering non-perturbed cells.
- Evident from the text: scRNA-seq depth limits direct measurement of each cell’s mutational profile in most cases, and perturbations causing cell death may skew observed perturbation rates because KO cells can be selectively depleted.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
13 Valid · 1 Not valid · 2 Not checked · 123 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“We recently introduced expanded CRISPR-compatible CITE-seq (ECCITE-seq), which simultaneously measures transcriptomes, surface protein levels, and perturbations at singlecell resolution [18].”
What the sources say
- Supportedcites [18] Mimitou, E. P. et al. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells. Nat. Methods 16, 409–412 (2019). source
The Results section describes ECCITE-seq measuring CRISPR perturbations through detected sgRNAs alongside mRNA and protein expression in single cells. The Discussion also states that the method can interrogate the transcriptome and proteins in response to perturbations. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Specifically, we discover that the kelch-like protein KEAP1 and the transcriptional activator NRF2, mediate levels of PD-L1 upregulation after IFN γ stimulation.”
- Also stated in: § RESULTS · plain
“we find that the kelch-like protein KEAP1 and the transcriptional activator NFE2L2 (also known as NRF2), both of which are frequently mutated in human cancers [23], can modify PD-L1 levels.”
What the sources say
- Could not verifycites [23] Hast, B. E. et al. Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination. Cancer Res. 74, 808–817 (2014). sourceExperimental — accuracy not yet measured
The Results section, “Connecting cancer-derived KEAP1 mutations with NRF2 activity,” links KEAP1 mutants to NRF2 target-gene expression, but does not address PD-L1 or IFNγ stimulation. Searches for PD-L1 upregulation after IFNγ stimulation and for interferon-gamma/CD274 expression found no passage addressing that claim. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § RESULTS · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“First, as previously described [15], perturbation of the CUL3-SPOP complex interferes with the ubiquitination of PD-L1, directly enhancing its stability and protein expression level.”
What the sources say
- Supportedcites [15] Zhang, J. et al. Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance. Nature 553, 91–95 (2018). source
The Summary (page not specified) states that loss-of-function SPOP mutations compromise ubiquitination-mediated PD-L1 degradation and increase PD-L1 levels. It also reports that depleting SPOP stabilizes PD-L1 in cells, supporting the claimed effect of perturbing the CUL3–SPOP pathway. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We identified five positive regulators (PD-L1 downregulation upon perturbation) and three negative regulators, a subset of which had been previously validated [9,11,13,16,17,29].”
What the sources say
- Supportedcites [9] Moon, J. W. et al. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma. Sci. Rep. 7, 17810 (2017). source
The citation supports the sentence’s claim that some positive regulators had been previously validated, not the citing authors’ own five-versus-three count. In the Results section on IFNγ-induced PD-L1 expression (page unavailable), inhibiting JAK2 or STAT1 reduced PD-L1 protein in EBV-positive gastric carcinoma cells. (LLM, conf=0.87)
- Supportedcites [11] Garcia-Diaz, A. et al. Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 19, 1189–1201 (2017). source
The citation supports the sentence’s claim that some of the regulators had been previously validated, not the citing authors’ own count of five positive and three negative regulators. In the Results section (page unavailable), the source reports that silencing JAK1, JAK2, STAT1, and IRF1 inhibited PD-L1 expression. (LLM, conf=0.88)
- Supportedcites [13] Hogg, S. J. et al. BET-bromodomain inhibitors engage the host immune system and regulate expression of the immune checkpoint ligand PD-L1. Cell Rep. 18, 2162–2174 (2017). source
The citation is attached to the statement that a subset of the regulators had been previously validated, not to the citing authors’ count of five positive and three negative regulators. The Results report that Brd4 knockdown significantly decreased PD-L1 expression, validating Brd4 as a positive regulator. (LLM, conf=0.91)
- Supportedcites [16] Burr, M. L. et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature 549, 101–105 (2017). source
The citation is attached to the statement that some regulators had been previously validated, not to the citing authors’ own count of five positive and three negative regulators. The Abstract and Extended Data Figure 1 identify CMTM6 as a positive regulator and report that its depletion reduces PD-L1, supporting it as one previously validated example. No page numbers are available in our copy. (LLM, conf=0.91)
- Supportedcites [17] Mezzadra, R. et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature 549, 106–110 (2017). source
The sentence presents the five-positive/three-negative count as the citing authors’ own finding; the citations support its statement that some regulators had previously been validated. Mezzadra et al. report that interfering with CMTM6 reduces PD-L1 protein expression and that CMTM4 shares this regulatory function (Abstract; page not given). This supports the cited prior-validation point, not the citing authors’ count. (LLM, conf=0.84)
- Could not verifycites [29] Nguyen, T., Nioi, P. & Pickett, C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291–13295 (2009). sourceExperimental — accuracy not yet measured
The citation is attached to the statement that some regulators had been previously validated, not to the citing authors’ count of five positive and three negative regulators. The Nrf2-Keap1 Regulatory Pathway and Molecular Mechanisms Controlling Nrf2 Stabilization sections discuss Nrf2 regulation, but the passages found when searching for PD-L1 and immune-checkpoint regulation do not address PD-L1 or validate its regulators. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“we verified that perturbation of BHLH transcription factor MYC [12] and the ubiquitin ligase CUL3 [15] both increased PD-L1 protein levels, consistent with previous reports.”
What the sources say
- Not checked — no full text of the sourcecites [12] Zou, J. et al. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells. Mol. Immunol. 101, 203–209 (2018). source
- Supportedcites [15] Zhang, J. et al. Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance. Nature 553, 91–95 (2018). source
Citation [15] is attached to CUL3, not MYC. In the SUMMARY, the paper reports that depletion of Cullin 3 elevated endogenous PD-L1 protein abundance. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
80 more claims
Create a free account to see all 139 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 18
- It may state two separate claims as one. 40
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three CITE-seq datasets have protein and RNA counts that are downloadable separately6,9.”
From scPerturb: harmonized single-cell perturbation data (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There are a number of existing methods that perform perturbation-effect analysis in single-cell omics data, but none of them achieve guaranteed confounder identification, which is a necessary condition for interpretable causal-effect estimation.”
From Causal identification of single-cell experimental perturbation effects with CINEMA-OT (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“induces immune evasion by targeting its ligand, programmed cell death 1 (PD-1) on activated T cells, resulting in T cell exhaustion1–4.”
From PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells (2022) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Variability from experimental conditions, including transduction efficiency, RNA sequencing depth, reagent chemistry, and timing of collection, further dilutes the true perturbation-derived signal.”
From Predicting cellular responses to perturbation across diverse contexts with State (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mixscape assumes that the distribution of the NP cells is identical to that of cells expressing non-targeting gRNAs (NT) and hence tries to gauge the distribution of KO cells.”
From A mini-review on perturbation modelling across single-cell omic modalities (2024) · cites this paper as [35]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ CITE-seq experiment
“cells from all experimental conditions were pooled at the appropriate concentration (recovery of 10,000 cells per lane).”
§ CITE-seq data library construction, sequencing and data analyses
“We ran 1 lane of 10x Genomics 5' (Chromium Single Cell Immune Profiling Solution v1.0, #1000014, #1000020, #1000151) aiming for 20,000 cell recovery per lane.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS-ONLY REFERENCES
“across two different gRNAs (IFNGR1g2 and PDL1g1).”
§ METHODS-ONLY REFERENCES
“DE was performed using the same number of sampled IFNGR2g1, PDL1g1 and nontargeting control cells.”
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Self-citationRobinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Integrated analysis of single cell transcriptomic data across conditions, technologies, and species
Butler, A., & Satija, R. (2017) · doi:10.1101/164889 · Cited by 13,200
Self-citationIntegrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Self-citationGenome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw377 · Cited by 10,799
Cited by
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Self-citationBest practices for single-cell analysis across modalities
Heumos, L., Schaar, A. C., Lance, C., Litinetskaya, A., Drost, F., Zappia, L., Lücken, M. D., Strobl, D. C., Henao, J., Curion, F., et al. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00586-w · Cited by 1,051
“3).”
CRISPR technology: A decade of genome editing is only the beginning
Wang, J. Y., & Doudna, J. A. (2023) · Science · doi:10.1126/science.add8643 · Cited by 1,049
“One exciting area of development in the readout of CRISPR screens is new methods that provide simultaneous proteomic, epigenetic, and/or transcriptomic analyses, such as Procode (62), Perturb-ATAC (63), Perturb-seq (64), and ECCITE-seq (65), which can provide a wealth of information.”
BackgroundMapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq
Replogle, J. M., Saunders, R. A., Pogson, A. N., Hussmann, J. A., Lenail, A., Guna, A., Mascibroda, L., Wagner, E. J., Adelman, K., Lithwick-Yanai, G., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.013 · Cited by 795
Regulatory mechanisms of PD-1/PD-L1 in cancers
Lin, X., Kang, K., Chen, P., Zeng, Z., Li, G., Xiong, W., Yi, M., & Xiang, B. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02023-w · Cited by 784
Metadata
- Authors
- Papalexi, E., Mimitou, E. P., Butler, A. W., Foster, S., Bracken, B., Mauck, W. M., Wessels, H.-H., Hao, Y., Yeung, B. Z., Smibert, P., & Satija, R.
- Affiliations
- New York Genome Center (US)
- BioLegend (United States) (US)
- Corresponding author
- Satija, Rahul
- ORCID
- Venue
- Nature Genetics
- Published
- 2021-03
- Volume
- 53
- Issue
- 3
- Pages
- 322-331
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC8011839
- OpenAlex
- W3133712085
- Semantic Scholar
- 664ab6fb37788415f4ba484f292002d64b38c846
- Cited by
- 237
- References
- 57
- Citations by year
- 2026: 62 · 2025: 51 · 2024: 49 · 2023: 34 · 2022: 21 · 2021: 19
- FWCI
- 14.81
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (DP2HG009623-01, RM1HG011014-01, R21HG009748-03)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- PD-L1, immune checkpoint, Keap1, Nrf2, interferon-gamma signaling, T cell suppression, signal-to-noise ratio, post-transcriptional regulation, transcriptional regulation, cancer immunotherapy resistance
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, THP-1 Cells, Immune Checkpoint Proteins, Bromodomain Containing Proteins, Humans, Transcription Factors, Reproducibility of Results, Receptors, Interferon, Cell Cycle Proteins, Cullin Proteins, NF-E2-Related Factor 2, B7-2 Antigen, Single-Cell Analysis, Signal-To-Noise Ratio, B7-H1 Antigen, Programmed Cell Death 1 Ligand 2 Protein, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterizing the molecular regulation of inhibitory immune checkpoints with multimodal single-cell screens. https://app.cochat.ai/papers/10.1038/s41588-021-00778-2
- The paper
- Papalexi, E., Mimitou, E. P., Butler, A. W., Foster, S., Bracken, B., Mauck, W. M., Wessels, H.-H., Hao, Y., Yeung, B. Z., Smibert, P., & Satija, R. (2021). Characterizing the molecular regulation of inhibitory immune checkpoints with multimodal single-cell screens. Nature Genetics. https://doi.org/10.1038/s41588-021-00778-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.